Investigating clonal relationship through cytogenetic and molecular studies is crucial in these scenarios, as composite lymphoma is usually clonally unrelated whereas CLL with secondary acquisition of t(11;14)(q13;q32)/IGH::CCND1 implies clonal relatedness and disease progression. Here, CCND1 is linked to lymphoma.